These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 37451379)

  • 41. Advanced Glycation End Products, Diabetes, and Bone Strength.
    Yamamoto M; Sugimoto T
    Curr Osteoporos Rep; 2016 Dec; 14(6):320-326. PubMed ID: 27704396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perspectives on signaling for biological- and processed food-related advanced glycation end-products and its role in cancer progression.
    Eva TA; Barua N; Chowdhury MM; Yeasmin S; Rakib A; Islam MR; Emran TB; Simal-Gandara J
    Crit Rev Food Sci Nutr; 2022; 62(10):2655-2672. PubMed ID: 33307763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives.
    Liu J; Pan S; Wang X; Liu Z; Zhang Y
    Eur J Med Res; 2023 Dec; 28(1):553. PubMed ID: 38042909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
    Yamagishi S; Matsui T; Nakamura K
    Curr Drug Targets; 2007 Oct; 8(10):1138-43. PubMed ID: 17979674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases.
    Byun K; Yoo Y; Son M; Lee J; Jeong GB; Park YM; Salekdeh GH; Lee B
    Pharmacol Ther; 2017 Sep; 177():44-55. PubMed ID: 28223234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does accumulation of advanced glycation end products contribute to the aging phenotype?
    Semba RD; Nicklett EJ; Ferrucci L
    J Gerontol A Biol Sci Med Sci; 2010 Sep; 65(9):963-75. PubMed ID: 20478906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality Criteria for Studies on Dietary Glycation Compounds and Human Health.
    Hellwig M; Humpf HU; Hengstler J; Mally A; Vieths S; Henle T
    J Agric Food Chem; 2019 Oct; 67(41):11307-11311. PubMed ID: 31514500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Food advanced glycation end products as potential endocrine disruptors: An emerging threat to contemporary and future generation.
    Ravichandran G; Lakshmanan DK; Raju K; Elangovan A; Nambirajan G; Devanesan AA; Thilagar S
    Environ Int; 2019 Feb; 123():486-500. PubMed ID: 30622074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advanced glycation and glycoxidation end products in bone.
    Wang B; Vashishth D
    Bone; 2023 Nov; 176():116880. PubMed ID: 37579812
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Perspective on the Impact of Advanced Glycation End Products in the Progression of Diabetic Nephropathy.
    Khanam A; Ahmad S; Husain A
    Curr Protein Pept Sci; 2023; 24(1):2-6. PubMed ID: 36366848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
    Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
    Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advanced glycation end products in musculoskeletal system and disorders.
    Suzuki A; Yabu A; Nakamura H
    Methods; 2022 Jul; 203():179-186. PubMed ID: 32987130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of Non-Enzymatic Glycation in Neurodegenerative Diseases: Role of Natural Products in Prevention.
    Ahmad S; Farhan M
    Adv Neurobiol; 2016; 12():125-51. PubMed ID: 27651252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting advanced glycation with pharmaceutical agents: where are we now?
    Borg DJ; Forbes JM
    Glycoconj J; 2016 Aug; 33(4):653-70. PubMed ID: 27392438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dietary Advanced Glycation End Products: Digestion, Metabolism and Modulation of Gut Microbial Ecology.
    Snelson M; Coughlan MT
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30678161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advanced Glycation End Products: Do They Impair Bone Health in Diabetes?
    Papachristou S; Rizzo M; Papanas N
    Exp Clin Endocrinol Diabetes; 2022 Oct; 130(10):636-637. PubMed ID: 35977693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of advanced glycation end products (AGEs) in osteoporosis in diabetes.
    Yamagishi S
    Curr Drug Targets; 2011 Dec; 12(14):2096-102. PubMed ID: 22023404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation.
    Sourris KC; Watson A; Jandeleit-Dahm K
    Handb Exp Pharmacol; 2021; 264():395-423. PubMed ID: 32809100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advanced Glycation End Products, Bone Health, and Diabetes Mellitus.
    Jiang J; Zhao C; Han T; Shan H; Cui G; Li S; Xie Z; Wang J
    Exp Clin Endocrinol Diabetes; 2022 Oct; 130(10):671-677. PubMed ID: 36257297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.